Physician profile
Patricia Lyons
NPI 1063454189
$388.07
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.17 · 2020: $24.60 · 2021: $73.81 · 2022: $76.21 · 2023: $87.46 · 2024: $66.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $137 · Education: $16.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $137.39 |
| Education | $16.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $86.31 | 2019-2024 | Farxiga |
| Fresenius USA Marketing, INC. | $76.35 | 2019-2023 | Velphoro |
| Boston Scientific Corporation | $56.36 | 2021-2022 | |
| Vifor Pharma, INC. | $47.94 | 2019-2023 | Veltassa |
| Bayer Healthcare Pharmaceuticals INC. | $43.40 | 2022-2023 | |
| Travere Therapeutics, INC. | $29.64 | 2024 | |
| Ardelyx, INC. | $18.77 | 2024 | Ibsrela |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.90 | 2023 | Jardiance |
| Akebia Therapeutics INC | $13.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patricia Lyons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.